CRY News and Press, CryoLife Inc. From 04/14/19

The best “sure bets” currently are Medicare stocks Healthcare stocks number in the several hundreds. Biotechs alone count over 200. Which stocks present odds-on opportunities? Better than the others? How to tell? Answer: Find a good stock price forecaster. A forecaster who ...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The week ahead sees a heavy dose of healthcare companies presenting at investor con...

ATLANTA , April 3, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 18 th Annual Needham Healthcare Conference on Wednesday, April 10, 2019 at the Westin...

ATLANTA , March 5, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Cowen and Company 39 th Annual Health Care Conference on Monday, March 11, 2019 at Th...

Albireo Pharma (NASDAQ: ALBO ) initiated with Buy rating and $62 (131% upside) price target at H.C. Wainwright. More news on: Albireo Pharma, Inc., Centene Corporation, WellCare Health Plans, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

CryoLife, Inc. (CRY) Q4 2018 Earnings Conference Call February 14, 2019 8:30 AM ET Company Participants Lynn Lewis - Investor Relations, Gilmartin Group Pat MacKin - Chief Executive Officer Ashley Lee - Chief Financial Officer Conference Call Participants Jason Mills - Cana...

CryoLife (NYSE: CRY ): Q4 Non-GAAP EPS of $0.05 beats by $0.01 ; GAAP EPS of -$0.05 misses by $0.09 . Revenue of $67.8M (+28.3% Y/Y) beats by $0.75M . Press Release More news on: CryoLife, Inc., Earnings news and commentary, Healthcare stocks news,

ATLANTA , Feb. 13, 2019 /PRNewswire/ --   Fourth Quarter and Recent Business Highlights: Total revenues were $67.8 million in the fourth quarter of 2018, reflecting year over year growth of 28% and an 8% increase on a non-GAAP constant currency basis compared to the f...

CryoLife (NYSE: CRY ) is scheduled to announce Q4 earnings results on Wednesday, February 13th, after market close. More news on: CryoLife, Inc., Earnings news and commentary, , Healthcare stocks news, Read more ...